Achieving Targeted Treatment Outcomes in IBD - Episode 8

Combination Therapy in Inflammatory Bowel Disease

Published on: August 6, 2024

Silvio Danese, MD, PhD , Bruce Sands, MD , Jean-Frederic Colombel, MD

Medical experts in inflammatory bowel disease discuss the current evidence on dual advanced therapy for ulcerative colitis and Crohn's disease, highlighting the potential benefits, while also addressing the challenges and complexity of treatment management.

EP. 1: Treat-to-target in Inflammatory Bowel Disease

EP. 3: Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease

EP. 4: Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease

EP. 5: Suboptimal Treatment of Inflammatory Bowel Disease in Clinical Practice

EP. 6: Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease

EP. 7: Considerations for Choosing Advanced Treatments and Setting Patient Expectations

Now Viewing

EP. 8: Combination Therapy in Inflammatory Bowel Disease

EP. 9: Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment Changes

What is the current evidence on Advanced Combination Therapy for UC and CD? What are the benefits and challenges of this approach?